34,694 Shares in Xylem Inc. (NYSE:XYL) Bought by First American Trust FSB

First American Trust FSB bought a new position in Xylem Inc. (NYSE:XYL) in the 4th quarter, Holdings Channel.com reports. The firm bought 34,694 shares of the industrial products company’s stock, valued at approximately $3,968,000.

Several other hedge funds have also added to or reduced their stakes in XYL. Bruce G. Allen Investments LLC bought a new stake in Xylem in the fourth quarter worth $27,000. NBC Securities Inc. bought a new stake in Xylem in the third quarter worth $38,000. KB Financial Partners LLC bought a new stake in Xylem in the first quarter worth $42,000. Coppell Advisory Solutions LLC bought a new stake in Xylem in the second quarter worth $45,000. Finally, ST Germain D J Co. Inc. bought a new stake in Xylem in the second quarter worth $46,000. 87.96% of the stock is owned by institutional investors.

Xylem Trading Down 0.6 %

XYL stock traded down $0.82 during trading on Monday, reaching $127.29. The company had a trading volume of 968,617 shares, compared to its average volume of 1,143,641. Xylem Inc. has a 52 week low of $87.59 and a 52 week high of $130.86. The company has a market cap of $30.86 billion, a P/E ratio of 46.80, a PEG ratio of 2.55 and a beta of 1.10. The business has a 50 day moving average of $126.62 and a 200 day moving average of $111.64. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.76 and a quick ratio of 1.30.

Xylem (NYSE:XYL) last released its quarterly earnings results on Tuesday, February 6th. The industrial products company reported $0.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.03. The company had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.05 billion. Xylem had a net margin of 8.27% and a return on equity of 9.65%. Xylem’s revenue was up 40.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.92 earnings per share. As a group, sell-side analysts forecast that Xylem Inc. will post 4.13 earnings per share for the current fiscal year.

Xylem Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, March 20th. Shareholders of record on Wednesday, February 21st were issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Tuesday, February 20th. This is a boost from Xylem’s previous quarterly dividend of $0.33. Xylem’s dividend payout ratio is 52.94%.

Insiders Place Their Bets

In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The transaction was disclosed in a filing with the SEC, which is available at this link. In related news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $122.89, for a total transaction of $122,890.00. Following the transaction, the chief accounting officer now owns 2,935 shares in the company, valued at $360,682.15. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction that occurred on Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the transaction, the senior vice president now owns 11,750 shares in the company, valued at approximately $1,431,032.50. The disclosure for this sale can be found here. Corporate insiders own 0.27% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the stock. Citigroup boosted their price target on shares of Xylem from $126.00 to $139.00 and gave the stock a “neutral” rating in a research note on Monday, April 8th. Robert W. Baird upped their price objective on shares of Xylem from $141.00 to $148.00 and gave the company an “outperform” rating in a research note on Thursday, March 21st. Royal Bank of Canada upped their price objective on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Wednesday, February 7th. BNP Paribas assumed coverage on shares of Xylem in a research note on Tuesday, March 12th. They set an “outperform” rating and a $150.00 price objective for the company. Finally, Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research note on Thursday, January 4th. Four investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat.com, Xylem has an average rating of “Moderate Buy” and an average price target of $135.44.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.